Full metadata record
DC FieldValueLanguage
dc.contributor.authorWesthuizen, Leandi van der-
dc.contributor.authorWeisner, Jörn-
dc.contributor.authorTaher, Abu-
dc.contributor.authorLandel, Ina-
dc.contributor.authorQuambusch, Lena-
dc.contributor.authorLindemann, Marius-
dc.contributor.authorUhlenbrock, Niklas-
dc.contributor.authorMüller, Matthias P.-
dc.contributor.authorGreen, Ivan R.-
dc.contributor.authorPelly, Stephen C.-
dc.contributor.authorRauh, Daniel-
dc.contributor.authorOtterlo, Willem A. L. van-
dc.date.accessioned2024-03-04T14:59:07Z-
dc.date.available2024-03-04T14:59:07Z-
dc.date.issued2022-02-16-
dc.identifier.urihttp://hdl.handle.net/2003/42375-
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-24212-
dc.description.abstractAkt is a protein kinase that has been implicated in the progression of cancerous tumours. A number of covalent allosteric Akt inhibitors are known, and based on these scaffolds, a small library of novel potential covalent allosteric imidazopyridine-based inhibitors was designed. The envisaged compounds were synthesised, with click chemistry enabling a modular approach to a number of the target compounds. The binding modes, potencies and antiproliferative activities of these synthesised compounds were explored, thereby furthering the structure activity relationship knowledge of this class of Akt inhibitors. Three novel covalent inhibitors were identified, exhibiting moderate activity against Akt1 and various cancer cell lines, potentially paving the way for future covalent allosteric inhibitors with improved properties.en
dc.language.isoende
dc.relation.ispartofseriesChemMedChem;17(10)-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/de
dc.subjectAkt kinaseen
dc.subjectcovalent allosteric inhibitorsen
dc.subjectimidazopyridinesen
dc.subjectclick chemistryen
dc.subjectfragmentsen
dc.subject.ddc570-
dc.subject.ddc540-
dc.titleCovalent allosteric inhibitors of Akt generated using a click fragment approachen
dc.typeTextde
dc.type.publicationtypeResearchArticlede
dc.subject.rswkProtein-Serin-Threonin-Kinasende
dc.subject.rswkAllosterische Kontrollede
dc.subject.rswkImidazopyridinede
dc.subject.rswkClick-Chemiede
dc.subject.rswkInhibitorde
dcterms.accessRightsopen access-
eldorado.secondarypublicationtruede
eldorado.secondarypublication.primaryidentifierhttps://doi.org/10.1002/cmdc.202100776de
eldorado.secondarypublication.primarycitationL. van der Westhuizen, J. Weisner, A. Taher, I. Landel, L. Quambusch, M. Lindemann, N. Uhlenbrock, M. P. Müller, I. R. Green, S. C. Pelly, D. Rauh, W. A. L. van Otterlo, ChemMedChem 2022, 17, e202100776.de
Appears in Collections:Medizinische Chemie und Chemische Biologie



This item is protected by original copyright



This item is licensed under a Creative Commons License Creative Commons